RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Comparison of gliclazide vs linagliptin on hypoglycemia and cardiovascular events in type 2 diabetes mellitus: A systematic review.

Comparison of gliclazide vs linagliptin on hypoglycemia and cardiovascular events in type 2 diabetes mellitus: A systematic review.

Add to Collection
2022 Dec 15 Systematic Review and Meta Analysis V Mohan, S Wangnoo, S Das, R Dhediya… - … Journal of Diabetes, 2022 - ncbi.nlm.nih.gov

Full Author : ['Mohan, Viswanathan', 'Wangnoo, Subhash', 'Das, Sambit', 'Dhediya, Rajnish', 'Gaurav, Kumar']
Journal Title : World journal of diabetes
Chapter : Section4
Journal Year : 2022

BACKGROUND: Cardiovascular outcome trials have demonstrated cardiovascular safety of glimepiride (a sulfonylureas) against dipeptidyl peptidase-4 inhibitor linagliptin. Gliclazide (another newer sulfonylureas) has shown similar glycemic efficacy and 50% d..... Read More

Keywords : ['type diabetes mellitus', 'gliclazide vs linagliptin', 'systematic review', 'cardiovascular event', 'hypoglycemia', 'comparison']
PubMed Link : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791565/